Skip to main content

Together we are beating cancer

Donate now

Family history

Showing 12 out of 42 results
Data centre filled with rows of servers

Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk. Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk.

by Amy Warnock, Graeme Sneddon | News | 22 January 2025

22 January 2025

Microscopic image of core biopsy for infiltrating (invasive) ductal carcinoma, detected by screening mammogram

Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer

by Fiona Scott | News | 1 October 2024

1 October 2024

Radiographer looking at a mammogram image

Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​. Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​.

by Amy Warnock | In depth | 1 October 2024

1 October 2024

Steph Phillips, Dr Miriam Dixon-Zegeye & Professor Sarah Blagden

We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease. We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease.

by Tim Gunn | In depth | 19 September 2023

19 September 2023

Cosmetics

The good news is there’s no reason to be concerned about deodorants, bras, plastics and milk when it comes to breast cancer risk. The good news is there’s no reason to be concerned about deodorants, bras, plastics and milk when it comes to breast cancer risk.

by Nikki Smith | Analysis | 12 October 2017

12 October 2017

This entry is part 5 of 5 in the series Google Hangouts

We explore a new revolutionary gene editing technology called CRISPR that's taking labs by storm as scientists look to understand the genetics behind cancer. We explore a new revolutionary gene editing technology called CRISPR that's taking labs by storm as scientists look to understand the genetics behind cancer.

by Nick Peel | Analysis | 1 February 2016

1 February 2016

Women who carry an inherited fault in the gene BRIP1 are over three times more likely to develop ovarian cancer than those without the fault. Women who carry an inherited fault in the gene BRIP1 are over three times more likely to develop ovarian cancer than those without the fault.

by Cancer Research UK | News | 19 January 2016

19 January 2016